Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

21 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Idamycin Articles

Belinostat enters Ph I/II trial

3 September 2007

Pfizer and Teva resolve two law suits

27 November 2006

Gensia Sicor gets OK for generic idarubicin

13 May 2002

BioChem Pharma's Troxatyl starts Ph III in AML

5 April 2001

FDA Approves P&U's Idamycin-Pfs

3 March 1997

Novantrone Scheduled For Review Next Month

19 August 1996

US Drug Lag Does Not Exist, Claims FDA Study

15 January 1996

Sandoz MDR Drug Shows Promise In Early Trials

13 November 1995

Six New Ingredients For Japan's NHI List

19 June 1995

CPAC Approves Six Drugs In Japan

3 April 1995

Showing 1-10 of 10 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS